Mode
Text Size
Log in / Sign up
N/A N=15 Treatment

Effects of Passive Heat Therapy on Oxygen Consumption and Cardiovascular Fitness in Adults

Heart Failure · Heart Diseases · Cardiovascular Diseases · Endothelial Dysfunction

Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Oct 2022
Primary outcome: Primary: Change in Blood Pressure — -2.94; 0.85 mmHg

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Heat Therapy Treatment (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
University of Kansas Medical Center
Primary completion
Jul 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Blood Pressure
-2.94; 0.85
PRIMARY
Change in Stroke Volume
9.02
PRIMARY
Change in Stroke Volume Variation
PRIMARY
Change in Cardiac Index
-0.36
PRIMARY
Change in Systemic Vascular Resistance
9.02
PRIMARY
Change in Maximum Oxygen Consumption (VO2max)
-0.13
PRIMARY
Change in Concentration of Heat Shock Proteins
PRIMARY
Change in Concentration of Nitric Oxide
PRIMARY
Change in Concentration of Pro/Anti-inflammatory Markers

Summary

The purpose of this study is to determine if enhanced endothelial arterial distensibility observed with heat therapy translates into improved cardiorespiratory fitness. The following aims are proposed: Aim 1: to determine if chronic heat therapy results in improvements in cardiovascular function. Aim 2: To examine potential mechanism(s) of action of heat therapy in cardiovascular function.

Eligibility Criteria

Exclusion Criteria

  • Current major cardiovascular disease (i.e.: recent myocardial infarction (heart attack), stroke, angina pectoris, high grade coronary vasculopathy or atherosclerosis, severe valvular disease, cardiac dysrhythmia that requires treatment.
  • Current treatment with steroids or immunosuppressive agents
  • Cancer
  • Serious liver disease
  • End-stage renal disease
  • Judgement by medical provider that heat therapy poses an undue burden or risk
  • Women who are pregnant or plan to become pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04026126). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search